We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,044 hedge funds and large institutions have $55.2B invested in Thermo Fisher Scientific in 2016 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 332 increasing their positions, 458 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more funds holding in top 10

Funds holding in top 10: 7893 (+15)

13% more call options, than puts

Call options by funds: $226M | Put options by funds: $201M

7% more capital invested

Capital invested by funds: $51.5B → $55.2B (+$3.71B)

0.13% less ownership

Funds ownership: 88.79%88.67% (-0.13%)

2% less first-time investments, than exits

New positions opened: 64 | Existing positions closed: 65

1% less funds holding

Funds holding: 1,0551,044 (-11)

28% less repeat investments, than reductions

Existing positions increased: 332 | Existing positions reduced: 458

Holders
1,044
Holders Change
-11
Holders Change %
-1.04%
% of All Funds
27.85%
Holding in Top 10
93
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+19.23%
% of All Funds
2.48%
New
64
Increased
332
Reduced
458
Closed
65
Calls
$226M
Puts
$201M
Net Calls
+$25.2M
Net Calls Change
-$33.8M
Name Holding Trade Value Shares
Change
Change in
Stake
MLL
326
Moody Lynn & Lieberson
Massachusetts
$9.86M -$309K -2,007 -3%
GH
327
GAM Holding
Switzerland
$9.86M -$835K -5,418 -8%
PAM
328
Panagora Asset Management
Massachusetts
$9.81M +$12K +78 +0.1%
Mitsubishi UFJ Asset Management
329
Mitsubishi UFJ Asset Management
Japan
$9.65M +$227K +1,470 +2%
AAM
330
Advisors Asset Management
Colorado
$9.64M -$206K -1,336 -2%
DILH
331
Dai-ichi Life Holdings
Japan
$9.57M +$67.5K +438 +0.7%
HC
332
Henshaw Capital
Massachusetts
$9.54M
DG
333
Davidson & Garrard
Virginia
$9.54M -$212K -1,375 -2%
Baird Financial Group
334
Baird Financial Group
Wisconsin
$9.48M -$24.8K -161 -0.3%
LIC
335
Lodestar Investment Counsel
Illinois
$9.36M +$268K +1,740 +3%
DADC
336
D.A. Davidson & Co
Montana
$9.13M +$2.37M +15,406 +37%
Janney Montgomery Scott
337
Janney Montgomery Scott
Pennsylvania
$9.09M -$8.85M -57,453 -50%
PPCM
338
Pillar Pacific Capital Management
California
$9.02M -$187K -1,213 -2%
SRC
339
Shufro Rose & Co
New York
$8.87M -$1.04M -6,726 -11%
CTA
340
Chesley Taft & Associates
Illinois
$8.71M -$185K -1,200 -2%
CCM
341
Channing Capital Management
Illinois
$8.71M
RWM
342
RKL Wealth Management
Pennsylvania
$8.62M -$155K -1,005 -2%
UB
343
UMB Bank
Missouri
$8.62M -$619K -4,016 -7%
Jones Financial Companies
344
Jones Financial Companies
Missouri
$8.58M -$574K -3,728 -6%
GHA
345
GW Henssler & Associates
Georgia
$8.56M -$798K -5,176 -9%
ERSOT
346
Employees Retirement System of Texas
Texas
$8.56M
AAF
347
Andra AP-fonden
Sweden
$8.53M +$231K +1,500 +3%
MSA
348
Mason Street Advisors
Wisconsin
$8.48M +$51.2K +332 +0.6%
PBT
349
Pictet Bank & Trust
Bahamas
$8.46M +$590K +3,830 +8%
CFG
350
Citizens Financial Group
Rhode Island
$8.39M -$19.6K -127 -0.2%

TMO Hedge Fund Activity: Q3 2016 in Review

1,044 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2016, worth a combined $55.2B — up 7.2% from $51.5B a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of TMO and 64 opened new positions — a net loss of 1 holder — while 458 trimmed existing stakes and 332 added.

The largest buyer was Winslow Capital Management, opening a new position worth an estimated $290M. The largest seller was Capital Research Global Investors, cutting an estimated $250M.

  • 1,044 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2016, down from 1,055 in Q2 2016.
  • Funds reported $55.2B of Thermo Fisher Scientific stock for Q3 2016, up 7.2% quarter-over-quarter.
  • 64 funds opened new Thermo Fisher Scientific positions in Q3 2016 and 65 closed out, a net change of -1 holder.
  • The largest Thermo Fisher Scientific buyer in Q3 2016 was Winslow Capital Management, an estimated $290M added.
  • The largest Thermo Fisher Scientific seller in Q3 2016 was Capital Research Global Investors, an estimated $250M sold.

Based on aggregated 13F filings for Q3 2016.